Bolt Biotherapeutics, Inc.
BOLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $11 | $9 | $27 |
| Short-Term Investments | $40 | $91 | $160 | $159 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $4 | $4 | $3 |
| Total Curr. Assets | $51 | $106 | $173 | $189 |
| Property Plant & Equip (Net) | $25 | $24 | $29 | $31 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $23 | $26 | $24 | $87 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $4 | $3 | $1 |
| Total NC Assets | $49 | $54 | $55 | $119 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $100 | $160 | $228 | $308 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $4 | $4 |
| Short-Term Debt | $2 | $3 | $2 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $3 | $2 | $2 | $3 |
| Other Curr. Liab. | $9 | $12 | $15 | $12 |
| Total Curr. Liab. | $16 | $20 | $23 | $21 |
| LT Debt | $23 | $17 | $20 | $22 |
| Deferred Rev, NC | $4 | $9 | $13 | $14 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $27 | $27 | $33 | $36 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $25 | $20 | $23 | $22 |
| Total Liabilities | $42 | $47 | $56 | $58 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$427 | -$364 | -$295 | -$207 |
| AOCI | $0 | $0 | -$1 | -$0 |
| Other Equity | $485 | $477 | $468 | $457 |
| Total Equity | $57 | $113 | $172 | $250 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $100 | $160 | $228 | $308 |
| Net Debt | $18 | $9 | $13 | -$3 |